Study authors evaluated the safety and efficacy of intravenous immunoglobulin plus the standard of care in the treatment of COVID-19 patients with moderate pneumonia.
The Pfizer request to expand emergency use authorization of its COVID-19 vaccine to include children ages 12 to 15 years will be evaluated “as quickly as possible.
People living with someone who has COVID-19 appear to get powerful protection against infection when they are given the Regeneron antibody cocktail, a new study shows.
To get a better understanding of the situation and how the future months could unfold, MPR sat down with Joshua Barocas, MD, an Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center.
In-hospital mortality for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients of all ages has declined throughout the pandemic period.
There was a nearly 6 percent drop in suicides in the United States last year, the largest annual decline in close to four decades, preliminary government data show.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
A funeral assistance program that will provide up to $9,000 to cover the burial costs of every American who died of COVID-19 will be launched next week by the Biden administration.
There is a “possible link” between the AstraZeneca COVID-19 vaccine and rare blood clots, but the benefits of the vaccine still outweigh the risks, the European Union drug regulator says.
Investigators analyzed the effects of TAK-101 from the induction of gliadin-specific T-cell tolerance in patients with biopsy-confirmed celiac disease.
A team of researchers investigated MRI findings in association with EEG features for patients with COVID-19 and sought to better define and understand the features of COVID-19-related encephalopathy.
